The expression of BCL9L is up-regulated in pancreatic cancer34, and knockdown of BCL9L diminishes TGF-β-induced EMT responses in pancreatic cancer cells and inhibits liver metastasis in vivo32. This evidence concerns the gene BCL9L and familial pancreatic carcinoma.